<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">london-journal-of-medical-and-health-research</journal-id>
<journal-title-group>
<journal-title>London Journal of Medical and Health Research</journal-title>
</journal-title-group>
<issn publication-format="print">2515-5784</issn>
<issn publication-format="electronic">2515-5792</issn>
<publisher><publisher-name>JournalsPress</publisher-name></publisher>
<self-uri xlink:href="https://journalspress.com/journal-seo-export/jats/105506.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">105506</article-id>
<title-group>
<article-title>Glaucoma Secondary to Uveitis Due to Posner Schlossman Syndrome</article-title>
</title-group>
<volume>25</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>26</lpage>
<abstract><p>Considering the clinical relevance of secondary glaucoma due to uveitis in posner-schlossman  syndrome (PSS), this study aims to evaluate the natural history of this condition in a patient. To  that end, we present the case of a 41-year-old man who experienced hyperemia, mild eye  discomfort and decrease in visual acuity in the left eye. The initial ophthalmological examination  revealed an intraocular pressure (IOP) of 30 mmhg in the left eye and 19 mmhg in the right, with  gonioscopy showing an open angle and trabecular pigmentation. The patient was treated with  topical corticosteroids, resulting in normalization of IOP. During follow-up, the patient experienced  recurrent episodes of anterior uveitis with IOP ranging from 22 mmhg to 28 mmhg until april 2024.  OCT examinations showed thinning of the nerve fiber layer, while visual fields remained normal.  Thus, it is observed that early diagnosis and treatment are crucial for the effective management of  secondary glaucoma due to uveitis, contributing to the preservation of visual function. It is  concluded that rapid intervention with topical corticosteroids is essential to prevent glaucomatous  neuropathy secondary to uveitis and to maintain the patient’s ocular health. </p></abstract>
<self-uri content-type="pdf" xlink:href="http://journalspress.com/LJMHR_Volume25/Glaucoma-Secondary-to-Uveitis-Due-to-Posner-Schlossman-Syndrome.pdf" />
<self-uri content-type="html" xlink:href="https://journalspress.com/glaucoma-secondary-to-uveitis-due-to-posner-schlossman-syndrome/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>Considering the clinical relevance of secondary glaucoma due to uveitis in posner-schlossman  syndrome (PSS), this study aims to evaluate the natural history of this condition in a patient. To  that end, we present the case of a 41-year-old man who experienced hyperemia, mild eye  discomfort and decrease in visual acuity in the left eye. The initial ophthalmological examination  revealed an intraocular pressure (IOP) of 30 mmhg in the left eye and 19 mmhg in the right, with  gonioscopy showing an open angle and trabecular pigmentation. The patient was treated with  topical corticosteroids, resulting in normalization of IOP. During follow-up, the patient experienced  recurrent episodes of anterior uveitis with IOP ranging from 22 mmhg to 28 mmhg until april 2024.  OCT examinations showed thinning of the nerve fiber layer, while visual fields remained normal.  Thus, it is observed that early diagnosis and treatment are crucial for the effective management of  secondary glaucoma due to uveitis, contributing to the preservation of visual function. It is  concluded that rapid intervention with topical corticosteroids is essential to prevent glaucomatous  neuropathy secondary to uveitis and to maintain the patient&#039;s ocular health. </p>
</sec>
</body>
</article>